OVERVIEW

2nd Annual MarketsandMarkets ImmunoBio Series is organized by MarketsandMarkets Conferences and will be held from Oct 14 - 15, 2024 at Freiburg Im Breisgau, Baden-Wurttemberg, Germany.

Key Performance Takeaways:
• Preclinical and Translational Immuno-Oncology Developments
• Biomarker Discovery Techniques: Explore novel strategies, including genomics, proteomics, metabolomics, and bioinformatics, to identify cutting-edge biomarkers in oncology.
• Precision Medicine Tailoring: Understand the pivotal role of biomarkers in customizing immunotherapy for individual patients, enhancing efficacy, and minimizing side effects.
Personalizing Cancer Treatment- Challenges and Opportunities
• Rigorous Biomarker Validation: Learn strategies and overcome challenges in validating biomarkers for clinical use, ensuring robust and reliable results.
• Bioinformatics and AI Analysis: Attend sessions on biomarker data analysis, employing machine learning and artificial intelligence approaches for comprehensive insights.
• Biomarker-Based Cancer Diagnostics Development: Gain insights into the development and commercialization of diagnostic tests and platforms based on biomarkers.
• Next Gen Antibodies and Targeted Therapies
• Immune Checkpoint Inhibitors and Combination Therapies
• Tumor Microenvironment and Cancer Biomarkers
• CAR-T cell therapy, T Cell Therapy, Adoptive Cell Therapy
• Cancer Vaccines and Cancer Microbiome
• Collaboration for Advancement: Explore sessions on fostering collaboration among academia, industry, and government agencies to drive biomarker research forward.